SG Americas Securities’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Buy
79,033
+37,395
+90% +$164K ﹤0.01% 2367
2025
Q4
$200K Buy
41,638
+18,265
+78% +$82.1K ﹤0.01% 2930
2025
Q3
$106K Sell
23,373
-3
-0% -$11 ﹤0.01% 3055
2025
Q2
$72K Sell
23,376
-26,594
-53% -$88.3K ﹤0.01% 2701
2025
Q1
$174K Sell
49,970
-19,149
-28% -$63.9K ﹤0.01% 2630
2024
Q4
$226K Buy
69,119
+16,250
+31% +$59.8K ﹤0.01% 2033
2024
Q3
$204K Buy
+52,869
New +$203K ﹤0.01% 2478
2024
Q2
Sell
-19,644
Closed -$51K 2799
2024
Q1
$51K Sell
19,644
-26,528
-57% -$68.7K ﹤0.01% 2765
2023
Q4
$115K Buy
46,172
+6,117
+15% +$12K ﹤0.01% 2653
2023
Q3
$81K Buy
+40,055
New +$84K ﹤0.01% 2846
2023
Q2
Sell
-52,397
Closed -$159K 2219
2023
Q1
$159K Buy
52,397
+27,016
+106% +$76.2K ﹤0.01% 2593
2022
Q4
$59K Sell
25,381
-4,094
-14% -$9.79K ﹤0.01% 2823
2022
Q3
$56K Buy
29,475
+7,957
+37% +$18.7K ﹤0.01% 2976
2022
Q2
$58K Buy
21,518
+8,274
+62% +$21.2K ﹤0.01% 3245
2022
Q1
$39K Sell
13,244
-8,381
-39% -$25.7K ﹤0.01% 2856
2021
Q4
$84K Sell
21,625
-577,724
-96% -$2.24M ﹤0.01% 3119
2021
Q3
$2.57M Buy
+599,349
New +$2M 0.01% 1049
2019
Q4
Sell
-35,701
Closed -$54K 3255
2019
Q3
$54K Sell
35,701
-37,397
-51% -$64.4K ﹤0.01% 2804
2019
Q2
$152K Buy
73,098
+15,644
+27% +$40K ﹤0.01% 2575
2019
Q1
$206K Buy
57,454
+9,078
+19% +$34.9K ﹤0.01% 2545
2018
Q4
$185K Sell
48,376
-56,480
-54% -$278K ﹤0.01% 2427
2018
Q3
$991K Buy
+104,856
New +$1.04M 0.01% 1691

Other funds holding ABUS